Refile: TABLE-Peptidream -2016/17 parent results
(Adds company forecast)
Aug 9 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Jun 30, 2017 Jun 30, 2016 Jun 30, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 4.90 4.33more than 7.00
(+13.1 pct) (+74.9 pct)
Operating 2.49 2.55more than 2.90
(-2.3 pct) (+83.2 pct)
Recurring 2.62 2.37more than 3.10
(+10.6 pct) (+58.5 pct)
Net 1.89 1.58more than 2.10
(+19.6 pct) (+57.5 pct)
EPS 16.54 yen 14.23 yen
EPS Diluted 14.56 yen 12.26 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T ((Tokyo
Headline News Desk +813 6441 1812))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner